BASFY
BASF SE
OTC Markets OTCQXUSDEQUITY
DELAYED
Last price
15.09
▲ 0.09 (0.60%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
15.12
Prev close
15.00
Day high
15.16
Day low
15.07
Volume
9.28K
Market cap
—
P/E (TTM)
—
52W range
11.93 – 16.25
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
+2.03%
+3.4%
1M
+8.87%
+5.1%
3M
-0.92%
-4.0%
6M
+4.50%
-6.6%
YTD
+16.44%
+4.1%
1Y
+7.79%
-12.2%
3Y
+22.29%
-51.9%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $59.66B | $61.44B | $68.90B | $87.33B | -2.9% |
| Operating revenue | $59.66B | $61.44B | $68.90B | $87.33B | -2.9% |
| Cost of revenue | $45.30B | $46.23B | $52.20B | $66.26B | -2.0% |
| Gross profit | $14.36B | $15.22B | $16.70B | $21.07B | -5.7% |
| Research & development | $2.00B | $1.97B | $2.13B | $2.30B | +1.3% |
| Selling, general & admin | $8.85B | $8.94B | $10.29B | $11.13B | -0.9% |
| Total operating expense | $11.50B | $12.25B | $13.44B | $13.71B | -6.1% |
| Operating income | $2.86B | $2.97B | $3.26B | $7.36B | -3.7% |
| Net interest income | -$516.00M | -$561.00M | -$649.00M | -$400.00M | +8.0% |
| Pre-tax income | $2.45B | $1.86B | $1.42B | $1.19B | +31.5% |
| Tax provision | $907.00M | $573.00M | $1.04B | $1.58B | +58.3% |
| Net income | $1.62B | $1.30B | $225.00M | -$627.00M | +24.7% |
| Net income to common | $1.62B | $1.30B | $225.00M | -$627.00M | +24.7% |
| Basic EPS | 0.46 | 0.36 | 0.06 | -0.18 | +25.5% |
| Diluted EPS | 0.45 | 0.36 | 0.06 | -0.18 | +24.8% |
| EBIT | $3.43B | $2.90B | $2.39B | $1.91B | +18.4% |
| EBITDA | $7.59B | $7.54B | $7.33B | $6.11B | +0.7% |
| Basic shares | 3.57B | 3.57B | 3.57B | 3.61B | -0.1% |
| Diluted shares | 3.58B | 3.58B | 3.58B | 3.61B | -0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.67B | $2.91B | $2.62B | $2.52B | -8.4% |
| Cash & short-term investments | $2.76B | $2.98B | $2.68B | $2.75B | -7.4% |
| Accounts receivable | $8.32B | $10.39B | $10.41B | $12.05B | -19.9% |
| Inventory | $12.06B | $13.58B | $13.80B | $15.94B | -11.2% |
| Total current assets | $31.68B | $31.23B | $31.47B | $37.42B | +1.4% |
| Property, plant & equipment | $25.41B | $27.20B | $24.08B | $22.97B | -6.6% |
| Goodwill & intangibles | $9.69B | $11.98B | $12.22B | $13.27B | -19.1% |
| Total assets | $76.17B | $80.42B | $77.39B | $84.47B | -5.3% |
| Total current liabilities | $16.41B | $17.04B | $15.87B | $20.44B | -3.7% |
| Current debt | $3.17B | $3.20B | $2.60B | $4.27B | -1.0% |
| Long-term debt | $18.49B | $19.13B | $17.10B | $15.19B | -3.4% |
| Total debt | $23.21B | $24.00B | $21.35B | $20.95B | -3.3% |
| Total liabilities | $41.84B | $43.53B | $40.75B | $43.55B | -3.9% |
| Retained earnings | $29.93B | $30.88B | $32.52B | $35.45B | -3.1% |
| Shareholder equity | $33.19B | $35.60B | $35.28B | $39.57B | -6.8% |
| Working capital | $15.27B | $14.19B | $15.60B | $16.98B | +7.6% |
| Net tangible assets | $23.50B | $23.62B | $23.06B | $26.30B | -0.5% |
| Shares issued | 892.52M | 892.52M | 892.52M | 893.85M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.62B | $1.30B | $225.00M | -$627.00M | +24.7% |
| Depreciation & amortisation | $4.17B | $4.65B | $4.94B | $4.20B | -10.4% |
| Change in working capital | $621.00M | $871.00M | $2.50B | -$2.05B | -28.7% |
| Operating cash flow | $5.61B | $6.95B | $8.11B | $7.71B | -19.2% |
| Capital expenditure | -$4.27B | -$6.20B | -$5.39B | -$4.38B | +31.2% |
| Investing cash flow | -$3.21B | -$5.08B | -$4.99B | -$3.78B | +36.9% |
| Share buybacks | -$355.00M | -$46.00M | -$70.00M | — | -671.7% |
| Dividends paid | -$2.09B | -$3.28B | -$3.09B | -$3.25B | +36.5% |
| Financing cash flow | -$2.42B | -$1.55B | -$2.90B | -$4.01B | -56.2% |
| Free cash flow | $1.34B | $748.00M | $2.72B | $3.33B | +79.5% |
| End cash position | $2.82B | $2.92B | $2.62B | $2.52B | -3.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $17.21B | $16.02B | $14.03B | $14.79B | $16.51B | +7.4% |
| Operating revenue | $17.21B | $16.02B | $14.03B | $14.79B | $16.51B | +7.4% |
| Cost of revenue | $12.87B | $11.87B | $10.93B | $11.12B | $12.09B | +8.5% |
| Gross profit | $4.33B | $4.15B | $3.11B | $3.67B | $4.42B | +4.4% |
| Research & development | $472.00M | $438.00M | $548.00M | $479.00M | $479.00M | +7.8% |
| Selling, general & admin | $2.28B | $2.13B | $2.21B | $2.25B | $2.19B | +7.3% |
| Total operating expense | $3.44B | $2.92B | $2.31B | $3.26B | $2.97B | +17.8% |
| Operating income | $892.00M | $1.23B | $800.00M | $412.00M | $1.46B | -27.5% |
| Net interest income | -$175.00M | -$118.00M | -$173.00M | -$103.00M | -$97.00M | -48.3% |
| Pre-tax income | $780.00M | $1.10B | $1.07B | $221.00M | $1.01B | -29.0% |
| Tax provision | $191.00M | $215.00M | $548.00M | $193.00M | $195.00M | -11.2% |
| Net income | $4.14B | $927.00M | $560.00M | $79.00M | $808.00M | +347.0% |
| Net income to common | $4.14B | $927.00M | $560.00M | $79.00M | $808.00M | +347.0% |
| Basic EPS | 1.20 | 0.27 | — | 0.02 | 0.23 | +350.9% |
| Diluted EPS | 1.20 | 0.27 | — | 0.02 | 0.23 | +350.9% |
| EBIT | $1.03B | $1.31B | $1.40B | $442.00M | $1.23B | -21.7% |
| EBITDA | $2.06B | $2.23B | $2.57B | $1.42B | $2.21B | -7.8% |
| Basic shares | 3.47B | 3.51B | — | 3.57B | 3.57B | -1.3% |
| Diluted shares | 3.47B | 3.51B | — | 3.57B | 3.57B | -1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $7.80B | $3.09B | $2.67B | $2.52B | $2.31B | +152.4% |
| Cash & short-term investments | $7.89B | $3.18B | $2.76B | $2.57B | $2.37B | +148.0% |
| Accounts receivable | $11.75B | $11.52B | $8.32B | $11.22B | $12.43B | +2.0% |
| Inventory | $13.81B | $12.91B | $12.06B | $13.63B | $13.87B | +7.0% |
| Total current assets | $38.78B | $37.60B | $31.68B | $31.90B | $33.19B | +3.1% |
| Property, plant & equipment | $25.85B | $25.70B | $25.41B | $25.76B | $26.66B | +0.6% |
| Goodwill & intangibles | $9.85B | $9.86B | $9.69B | $10.94B | $11.62B | -0.2% |
| Total assets | $83.87B | $81.77B | $76.17B | $77.67B | $81.42B | +2.6% |
| Total current liabilities | $20.91B | $19.65B | $16.41B | $18.18B | $18.11B | +6.4% |
| Current debt | $6.18B | $3.76B | $3.17B | $4.89B | $3.89B | +64.3% |
| Long-term debt | $18.83B | $19.91B | $18.49B | $18.96B | $18.88B | -5.4% |
| Total debt | $25.00B | $23.67B | $23.21B | $23.85B | $22.77B | +5.6% |
| Total liabilities | $46.47B | $46.29B | $41.84B | $44.16B | $44.07B | +0.4% |
| Retained earnings | $31.87B | $30.37B | $29.93B | $29.75B | $31.69B | +4.9% |
| Shareholder equity | $36.32B | $34.28B | $33.19B | $32.36B | $36.09B | +5.9% |
| Working capital | $17.87B | $17.95B | $15.27B | $13.72B | $15.08B | -0.4% |
| Net tangible assets | $26.47B | $24.42B | $23.50B | $21.42B | $24.46B | +8.4% |
| Shares issued | 892.52M | 892.52M | 892.52M | 892.52M | 892.52M | 0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $4.14B | $927.00M | $560.00M | $79.00M | $808.00M | — | +347.0% |
| Depreciation & amortisation | $1.03B | $925.00M | $1.18B | $982.00M | $981.00M | — | +11.8% |
| Change in working capital | -$427.00M | -$3.47B | $2.99B | $534.00M | -$3.13B | — | +87.7% |
| Operating cash flow | $524.00M | -$797.00M | $3.64B | $1.58B | -$982.00M | — | +165.7% |
| Capital expenditure | -$713.00M | -$578.00M | -$1.43B | -$1.05B | -$816.00M | — | -23.4% |
| Investing cash flow | $5.50B | -$375.00M | -$655.00M | -$1.11B | -$674.00M | — | +1,565.6% |
| Share buybacks | -$652.00M | -$494.00M | — | $0 | $0 | — | -32.0% |
| Dividends paid | -$1.97B | — | -$14.00M | -$2.05B | — | -$80.00M | — |
| Financing cash flow | -$1.50B | $1.57B | -$2.18B | -$223.00M | $1.09B | — | -195.4% |
| Free cash flow | -$189.00M | -$1.38B | $2.21B | $532.00M | -$1.80B | — | +86.3% |
| End cash position | $7.80B | $3.25B | $2.82B | $2.52B | $2.33B | — | +139.7% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
14.82
+1.83% from price
SMA 20
14.67
+2.88% from price
SMA 50
14.13
+6.78% from price
SMA 100
14.72
+2.52% from price
SMA 200
14.06
+7.29% from price
EMA 12
14.80
+1.95% from price
EMA 26
14.57
+3.60% from price
EMA 50
14.44
+4.49% from price
RSI (14)
62.2
Neutral
MACD (12,26,9)
0.24
Hist 0.03
ATR (14)
0.22
1.49% of price
Realised vol 30D
24.2%
Annualised
Bollinger upper
15.33
20, 2σ
Bollinger lower
14.00
20, 2σ
50 / 200 cross
Golden
14.13 vs 14.06
Trend bias
Above 200
+7.29%
Risk profile
Beta vs SPY
0.32
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
24.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-17.8%
Peak to trough
Max drawdown 5Y
-52.0%
Peak to trough
ATR 14
0.22
1.49% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
BASFY Opens Global SAP and Diaper Performance Lab in Mumbai
Zacks · 3d ago
Is BASF (XTRA:BAS) Undervalued After FDA Approval Of Its Tinosorb S UV Filter?
Simply Wall St. · 4d ago
Medical Plastics Market to Reach USD 48.77 billion by 2031, Growing at a CAGR of 7.0% — MarketsandMarkets™
GlobeNewswire · 4d ago
Microbial Inoculants & N-Fixing Microbes Market Report 2026–2035: Evaluating $6.7 Billion Forecast, Liquid Formulations, and Strategies of Novonesis, BASF, Corteva, and Bioceres
GlobeNewswire · 9d ago
Following UPM Biochemicals' Commercial Launch at Europe's Largest Biorefinery in Leuna, New Study Maps Growth Trajectory for Bio-Based Bisphenol Replacements
GlobeNewswire · 9d ago
Foam Packaging Market Report 2025–2034: Evaluating $33.8 Billion Projection, PE & PU Rigid Foams, and Market Shares of UFP Tech, Zotefoams, Sealed Air, and BASF
GlobeNewswire · 9d ago
Following Evonik's 24% Q2 EBITDA Surge and Raised 2026 Outlook, New Report Outlines Trajectory for Sustainable Polymeric Surfactants
GlobeNewswire · 10d ago
Private 5G Network Deployment Tracker & Forecasts 2026-2030 | Covers 9,300 Engagements Across 130 Countries
GlobeNewswire · 10d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.